The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

Tue, 01st Jun 2021 15:51

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

Tekmar Group PLC - provider of technology and services for offshore energy markets - Hires Derek Bulmer as new chief financial officer. Sue Hurst, the current CFO, steps down from the role on Tuesday but will remain on the board for a transition period. Bulmer was CFO and in-house counsel for AIM-listed radiation detection technology firm Kromek Group PLC from 2010 until last year. Prior to Kromek, he had worked at brick maker Ibstock PLC, among other employers. Tekmar also announced its annual results on Tuesday. For the 12 months ended March 31, it swung to pretax loss of GBP2.5 million from a profit of GBP2.0 million the year before, on revenue which declined 29% to GBP29.1 million from GBP40.9 million.

----------

Redx Pharma PLC - Macclesfield, England-based discovery of treatments for cancer and fibrotic disease - Chair Iain Ross steps down as a director immediately "to pursue other business opportunities". Redx makes Independent Non-Executive Director Peter Presland the interim chair as it starts search for new chair. "Iain has been the lynchpin in the turnaround of Redx, and we are very grateful for his innumerable contributions as chairman over the last four years," says Chief Executive Officer Lisa Anson. Ross says he remains "a supportive shareholder".

----------

Chamberlin PLC - West Midlands-based castings and engineering - New CEO Kevin Price and new Finance Director Alan Tomlinson join the board on Tuesday. Non-Executive Director Trevor Brown moves to executive director, responsible for company strategy, effective immediately, while David Flowerday resigns as non-executive director from Monday.

----------

Challenger Energy Group PLC - assets in Bahamas, Uruguay, Trinidad & Tobago and Suriname, previously known as Bahamas Petroleum Co PLC - Eytan Uliel formally takes up role as CEO. Simon Potter steps down as CEO but remains as non-executive director. Stephen Bizzell joins board as non-executive director, replacing Ross McDonald.

----------

Longboat Energy PLC - North Sea-focused exploration and production - Hires Nick Ingrassia as corporate development director. Ingrassia had joined Longboat back in September. Among other roles, he had worked at Faroe Petroleum PLC, whose former management team are behind Longboat Energy. Ingrassia's appointment comes alongside Longboat's announcement on Tuesday of three acquisitions to develop an exploration drilling programme on the Norwegian continental shelf. The acquisitions will be accompanied by a GBP35 million equity raise and are classified as a reverse takeover of Longboat under AIM rules.

----------

Trustpilot AS - Copenhagen-based online consumer reviews platform - Hires Joe Hurd as independent non-executive director. California-based Hurd is an independent public board director and adviser.

----------

India Capital Growth Fund Ltd - invests directly, or indirectly, in companies based in India - Hires Lynne Duquemin as non-executive director, effective immediately, as successor to Peter Niven, who will retire from the board at the end of 2021. Duquemin is a Guernsey resident with "deep experience of investment management and advisory services".

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Mar 2020 10:23

Redx Pharma Optimistic As Loss Narrows And Cancer Trial Progresses

Redx Pharma Optimistic As Loss Narrows And Cancer Trial Progresses

Read more
28 Feb 2020 18:47

UPDATE: Redx Pharma To Get GBP26 Million Injection Amid No Yesod Bid

UPDATE: Redx Pharma To Get GBP26 Million Injection Amid No Yesod Bid

Read more
28 Feb 2020 18:08

No Redx Pharma Takeover As Yesod Opts Not To Make Offer

No Redx Pharma Takeover As Yesod Opts Not To Make Offer

Read more
14 Feb 2020 17:11

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

Read more
28 Jan 2020 14:15

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

Read more
24 Jan 2020 11:51

Moulton Goodies Raises Stake In Redx Pharma To 42% From 18%

Moulton Goodies Raises Stake In Redx Pharma To 42% From 18%

Read more
9 Jan 2020 16:02

Redx Pharma nominates next drug development candidate

(Sharecast News) - Drug discovery and development company Redx Pharma announced the nomination of RXC007 as its next drug development candidate for the treatment of fibrosis on Thursday.

Read more
9 Jan 2020 11:17

Redx Pharma Nominates Another Anti-Fibrosis Drug Candidate

Redx Pharma Nominates Another Anti-Fibrosis Drug Candidate

Read more
31 Dec 2019 10:34

UK WINNERS & LOSERS SUMMARY: Redx Surges On Potential Takeover Offer

UK WINNERS & LOSERS SUMMARY: Redx Surges On Potential Takeover Offer

Read more
31 Dec 2019 09:12

Redx Pharma Shares Soar On Discussions Over Possible Takeover Offer

Redx Pharma Shares Soar On Discussions Over Possible Takeover Offer

Read more
31 Dec 2019 08:51

LONDON MARKET OPEN: Stocks Start Mostly Lower Amid Profit Taking

LONDON MARKET OPEN: Stocks Start Mostly Lower Amid Profit Taking

Read more
19 Nov 2019 12:29

Redx collaboration with MDC awarded Innovate UK funding

(Sharecast News) - Redx Pharma announced on Tuesday that Innovate UK has awarded biomedical catalyst funding to Redx and Medicines Discovery Catapult (MCD).

Read more
19 Nov 2019 11:53

Redx Pharma Secures Funding To Develop Lung Condition Therapies

Redx Pharma Secures Funding To Develop Lung Condition Therapies

Read more
19 Aug 2019 10:22

Redx Pharma Gets Approval To Escalate Dose In RXC004 Study

(Alliance News) - Redx Pharma PLC on Monday said it has successfully completed dosing of the first cohort of patients in its ongoing phase 1/2 study with RXC004.RXC004 is an oral porcupine

Read more
19 Aug 2019 09:43

Redx Pharma gets green light to escalate dose in RXC004 study

(Sharecast News) - Drug discovery and development company Redx Pharma has successfully completed dosing of the first cohort of patients in its ongoing phase 1 and 2 study with 'RXC004', it announced on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.